Effects of canine parvovirus strain variations on diagnostic test results and clinical management of enteritis in dogs

Jessica E. Markovich VCA Animal Referral and Emergency Center of Arizona, 1648 N Country Club Dr, Mesa, AZ 85201.

Search for other papers by Jessica E. Markovich in
Current site
Google Scholar
PubMed
Close
 DVM
,
Karla M. Stucker Baker Institute for Animal Health, Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Karla M. Stucker in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Alaina H. Carr VCA Animal Referral and Emergency Center of Arizona, 1648 N Country Club Dr, Mesa, AZ 85201.

Search for other papers by Alaina H. Carr in
Current site
Google Scholar
PubMed
Close
 DVM
,
Carole E. Harbison Baker Institute for Animal Health, Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Carole E. Harbison in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Janet M. Scarlett Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Janet M. Scarlett in
Current site
Google Scholar
PubMed
Close
 DVM, MPH, PhD
, and
Colin R. Parrish Baker Institute for Animal Health, Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Colin R. Parrish in
Current site
Google Scholar
PubMed
Close
 PhD

Abstract

Objective—To estimate the prevalence of canine parvovirus (CPV) strains among dogs with enteritis admitted to a referral hospital in the southwestern United States during an 11-month period and to compare diagnostic test results, disease severity, and patient outcome among CPV strains.

Design—Prospective observational study.

Animals—72 dogs with histories and clinical signs of parvoviral enteritis.

Procedures—For each dog, a fecal sample or rectal swab specimen was evaluated for CPV antigen via an ELISA. Subsequently, fecal samples (n = 42 dogs) and pharyngeal swab specimens (16) were obtained and tested for CPV antigen via an ELISA and CPV DNA via a PCR assay. For specimens with CPV-positive results via PCR assay, genetic sequencing was performed to identify the CPV strain.

Results—56 dogs tested positive for CPV via ELISA or PCR assay. For 42 fecal samples tested via both ELISA and PCR assay, 27 had positive results via both assays, whereas 6 had positive PCR assay results only. Ten pharyngeal swab specimens yielded positive PCR assay results. Genetic sequencing was performed on 34 fecal or pharyngeal swab specimens that had CPV-positive PCR assay results; 25 (73.5%) were identified as containing CPV type-2c, and 9 (26.5%) were identified as containing CPV type-2b. No association was found between CPV strain and disease severity or clinical outcome.

Conclusions and Clinical Relevance—CPV type-2b and CPV type-2c posed similar health risks for dogs; therefore, genetic sequencing of CPV does not appear necessary for clinical management of infected patients. The diagnostic tests used could detect CPV type-2c.

Abstract

Objective—To estimate the prevalence of canine parvovirus (CPV) strains among dogs with enteritis admitted to a referral hospital in the southwestern United States during an 11-month period and to compare diagnostic test results, disease severity, and patient outcome among CPV strains.

Design—Prospective observational study.

Animals—72 dogs with histories and clinical signs of parvoviral enteritis.

Procedures—For each dog, a fecal sample or rectal swab specimen was evaluated for CPV antigen via an ELISA. Subsequently, fecal samples (n = 42 dogs) and pharyngeal swab specimens (16) were obtained and tested for CPV antigen via an ELISA and CPV DNA via a PCR assay. For specimens with CPV-positive results via PCR assay, genetic sequencing was performed to identify the CPV strain.

Results—56 dogs tested positive for CPV via ELISA or PCR assay. For 42 fecal samples tested via both ELISA and PCR assay, 27 had positive results via both assays, whereas 6 had positive PCR assay results only. Ten pharyngeal swab specimens yielded positive PCR assay results. Genetic sequencing was performed on 34 fecal or pharyngeal swab specimens that had CPV-positive PCR assay results; 25 (73.5%) were identified as containing CPV type-2c, and 9 (26.5%) were identified as containing CPV type-2b. No association was found between CPV strain and disease severity or clinical outcome.

Conclusions and Clinical Relevance—CPV type-2b and CPV type-2c posed similar health risks for dogs; therefore, genetic sequencing of CPV does not appear necessary for clinical management of infected patients. The diagnostic tests used could detect CPV type-2c.

All Time Past Year Past 30 Days
Abstract Views 848 0 0
Full Text Views 2940 1811 143
PDF Downloads 1460 587 38
Advertisement